Discontinuation report ACT NABILONE

Last updated on 2021-09-23 History
Report ID 146066
Drug Identification Number 02393581
Brand name ACT NABILONE
Common or Proper name NABILONE 0.5MG CAPSULES
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) NABILONE
Strength(s) 0.5MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 50
ATC code A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2021-09-10
Remaining supply date 2021-09-10
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2021-09-23 French Compare
v1 2021-09-23 English Compare